There is provided a medicament for treating amyotrophic lateral sclerosis(ALS)or symptoms caused by ALS and/or suppressing the progression thereof, which ischaracterized in the usage, dosage and administration period of the pyrazolonederivativerepresented by the following formula (wherein each symbol indicates the samemeaningas that defined in the specification):(see formula I)